Skip to content
Proffi

PHARMAQ AS

Org. no. 886 953 402 · Private limited company (AS) · Active · Skogmo Industriområde, Industrivegen 50, 7863, OVERHALLA · OVERHALLA · 21.200 – Manufacture of pharmaceutical preparations

ActiveVAT registeredRegister of Business Enterprises
Organisation form
AS
Employees
297
Established
27 May 2004
Municipality
OVERHALLA
Industry code
21.200

PHARMAQ AS is a private limited company (as) registered in OVERHALLA since 2004. The organisation number is 886 953 402. The register lists 297 employees. The latest submitted annual accounts are for 2025.

Source: The Brønnøysund Register Centre · Last updated 21 November 2026 at 17:59

Overview

Quick overview

Status and key figures

Based on the latest submitted annual accounts (2025) and registry data.

Liquidity

Strong

9.02

How the figure is assessed

Current assets divided by current liabilities. Below 1.0 is weak, 1.0–1.5 needs attention and 1.5 or more is strong.

Profitability

Strong

66.9 %

How the figure is assessed

Operating profit divided by operating revenue. Below 0% is weak, 0–10% needs attention and 10% or more is strong.

Solidity

Strong

89.6 %

How the figure is assessed

Equity divided by assets. Below 10% is weak, 10–30% needs attention and 30% or more is strong.

Operating revenue
2.6 bn NOK
+29.2 % vs. the year before
Net result
1.5 bn NOK
Fiscal year 2025
Equity
5.9 bn NOK
Fiscal year 2025
Status
Active
Central Coordinating Register
Employees
297
Registered in the Central Coordinating Register
Founded
27 May 2004
Place
OVERHALLA
Industry
Manufacture of pharmaceutical preparations
21.200
Public contracts
–
Roles
8
People and entities
The gauges are calculated key figures with open thresholds, not a credit assessment. All amounts come from the Register of Company Accounts.

Calculated by us

Proffi Risk Indicator

Low risk

Based on status, solvency, liquidity, profitability, trend and how recent the accounts are. Public register data only.

This is an indicative assessment, not a credit rating. It does not replace your own due diligence before entering into an agreement.

Proffi+

Proffi estimated value

Calculating …

Indicative model estimate based on public accounting figures and typical industry multiples. Not an appraisal, a valuation or investment advice.

Development

Revenue and profit

RevenueResult

Development

Solvency and profitability (%)

SolidityProfitability

Registry data

Company information

Organisation number
886 953 402
Organisation form
Private limited company (AS)
Registered in the Central Coordinating Register
24 June 2004
Date of incorporation
27 May 2004
Number of employees
297
Language form
Norwegian Bokmål
Latest submitted annual accounts
2025
Deleted
Not provided
Bankruptcy date
Not provided

Addresses

Visiting and postal address

Business address

Skogmo Industriområde, Industrivegen 507863 OVERHALLAOVERHALLA municipalityNorge

Postal address

Not registered

Show on map

Industry

Industry and sector

  • 21.200

    Manufacture of pharmaceutical preparations(main industry)

    C Manufacturing › 21 Manufacture of basic pharmaceutical products and pharmaceutical preparations › 21.2 Manufacture of pharmaceutical preparations › 21.20 Manufacture of pharmaceutical preparations

    See the industry: largest companies and key figures →
    What does this industry cover?

    Inkluderer: Omfatter produksjon av legemidler: antisera og andre blodfraksjoner, vaksiner, diverse legemidler herunder homøopatiske preparater, kjemiske svangerskapsforebyggende produkter til utvendig bruk og hormonelle svangerskapsforebyggende legemidler, sement til beinoppbygging, medisinske diagnostiseringspreparater herunder graviditetstester, radioaktive in-vivo diagnostiseringsstoffer og bioteknologiske medisiner Inkluderer også: Omfatter også produksjon av medisinsk impregnert vatt, gas, bandasjer, forbindinger mv. og bearbeiding av plantevekster til medisinsk bruk (knusing, sortering, formaling) Ekskluderer: Produksjon av planteuttrekk (mint, verbena, kamille mv.) grupperes under: 10.83 Bearbeiding av te og kaffe. Produksjon av tannfyllinger og produksjon av dental sement grupperes under: 32.50 Produksjon av medisinske og tanntekniske instrumenter og utstyr. Produksjon av kirurgisk forheng grupperes under: 32.50 Produksjon av medisinske og tanntekniske instrumenter og utstyr. Produksjon av sement til rekonstruksjon av bein grupperes under: 32.50 Produksjon av medisinske og tanntekniske instrumenter og utstyr. Engroshandel med apotekvarer grupperes under: 46.46 Engroshandel med sykepleie- og apotekvarer. Butikkhandel med apotekvarer grupperes under: 47.73 Butikkhandel med apotekvarer. Forskning og utvikling av apotekvarer og bioteknologiske apotekvarer grupperes under: 72.1 Forskning og utviklingsarbeid innen naturvitenskap og teknikk. Pakking av apotekvarer grupperes under: 82.92 Pakkevirksomhet

Institutional sector code: Private aksjeselskaper mv. (2100)

Statutory purpose

Produksjon og salg av veterinærfarmasøytiske produkter, handel, ervervelse og drift av faste eiendommer og utnyttelse av naturforekomster, finansieringsvirksomhet, samt annen virksomhet i forbindelse med slike formål. Selskapet kan ved aksjetegning eller på annen måte, herunder ved långivning, interessere seg i andre foretagender med samme eller lignende formål.

Registry status

Registrations and status

  • Registered in the Register of Business Enterprises
  • Registered in the VAT register
  • Registered in the Register of Non-Profit Organisations
  • Registered in the Register of Foundations
  • Bankruptcy
  • In liquidation
  • In compulsory liquidation

Experiences

Reviews

Loading reviews …

Write a review

You must sign in with a verified email to write a review.

Accounts

Financial overview

Accounts and key figures

Fiscal year 2025 · Amounts in NOK

Data basis

3 stored years

Liquidity

Strong

9.02

How the figure is assessed

Current assets divided by current liabilities. Below 1.0 is weak, 1.0–1.5 needs attention and 1.5 or more is strong.

Profitability

Strong

66.9 %

How the figure is assessed

Operating profit divided by operating revenue. Below 0% is weak, 0–10% needs attention and 10% or more is strong.

Solidity

Strong

89.6 %

How the figure is assessed

Equity divided by assets. Below 10% is weak, 10–30% needs attention and 30% or more is strong.

Key numbers and development

Only reported amounts from the Register of Company Accounts

Accounting item202520242023Development
Operating revenue2,606,627,0002,017,487,0002,179,986,000
Operating profit1,744,399,0001,156,040,0001,321,191,000
Profit before tax1,876,384,0001,227,365,0001,381,036,000
Net result1,458,651,000949,003,0001,078,014,000
Total assets6,615,770,0004,993,092,0003,995,280,000
Equity5,924,458,0004,465,808,0003,521,526,000
Liabilities691,312,000527,285,000473,754,000
The gauges are calculated key figures with open thresholds. They are not a credit assessment.

Graphical analysis

3 fiscal years (2023–2025)

Operating revenue 2025
2,606,627,000 NOK
Net result 2025
1,458,651,000 NOK
Revenue growth
29.2 %

Revenue and profit

Amounts in NOK

Operating margin

Calculated by us, in percent

Equity and liabilities

Balance sheet in NOK

Register of Company Accounts

Annual accounts 2025

Period 2025-01-01 to 2025-12-31. Currency NOK. Audited annual accounts.

Income statement

Total operating revenue2,606,627,000 NOK
Total operating expenses862,229,000 NOK
Operating profit1,744,399,000 NOK
Net financial items131,985,000 NOK
Profit before tax1,876,384,000 NOK
Net result1,458,651,000 NOK

Assets

Total fixed assets379,778,000 NOK
Total current assets6,235,992,000 NOK
Total assets6,615,770,000 NOK

Equity and liabilities

Paid-in equity17,413,000 NOK
Retained earnings5,907,045,000 NOK
Total equity5,924,458,000 NOK
Current liabilities691,312,000 NOK
Total debt691,312,000 NOK
Total equity and liabilities6,615,770,000 NOK

Register of Company Accounts

Annual accounts 2024

Period 2024-01-01 to 2024-12-31. Currency NOK. Audited annual accounts.

Income statement

Total operating revenue2,017,487,000 NOK
Total operating expenses861,446,000 NOK
Operating profit1,156,040,000 NOK
Total financial income127,991,000 NOK
Total financial expenses44,563,000 NOK
Net financial items71,325,000 NOK
Profit before tax1,227,365,000 NOK
Net result949,003,000 NOK

Assets

Total fixed assets398,232,000 NOK
Total current assets4,594,860,000 NOK
Total assets4,993,092,000 NOK

Equity and liabilities

Paid-in equity17,413,000 NOK
Retained earnings4,448,394,000 NOK
Total equity4,465,808,000 NOK
Current liabilities484,151,000 NOK
Long-term liabilities43,134,000 NOK
Total debt527,285,000 NOK
Total equity and liabilities4,993,092,000 NOK

Register of Company Accounts

Annual accounts 2023

Period 2023-01-01 to 2023-12-31. Currency NOK. Audited annual accounts.

Income statement

Total operating revenue2,179,986,000 NOK
Total operating expenses858,795,000 NOK
Operating profit1,321,191,000 NOK
Total financial income73,850,000 NOK
Total financial expenses932,000 NOK
Net financial items59,846,000 NOK
Profit before tax1,381,036,000 NOK
Net result1,078,014,000 NOK

Assets

Total fixed assets415,608,000 NOK
Total current assets3,579,672,000 NOK
Total assets3,995,280,000 NOK

Equity and liabilities

Paid-in equity17,413,000 NOK
Retained earnings3,504,113,000 NOK
Total equity3,521,526,000 NOK
Current liabilities465,611,000 NOK
Long-term liabilities8,143,000 NOK
Total debt473,754,000 NOK
Total equity and liabilities3,995,280,000 NOK

Source: Register of Company Accounts, Brønnøysund Register Centre. Figures are shown as submitted, and historical years are never overwritten by newer submissions.

Key figures

Calculated by us

Key figures

Key figures 202520242023
Revenue growthChange in total operating revenue from the previous fiscal year.29.2 %-7.5 %–
Operating marginOperating profit divided by total operating revenue.66.9 %57.3 %60.6 %
Profit marginOrdinary profit before tax divided by total operating revenue.72 %60.8 %63.4 %
Equity ratioTotal equity divided by total assets.89.6 %89.4 %88.1 %
Current ratioTotal current assets divided by total current liabilities.9.029.497.69
Debt ratioTotal liabilities divided by total equity.0.120.120.13
Return on assetsOrdinary profit before tax plus financial expenses, divided by total assets.–25.5 %34.6 %
Return on equityNet profit divided by total equity.24.6 %21.3 %30.6 %

About the calculation

The key figures are calculated by us (formula version v1) from public accounts in the Register of Company Accounts. A figure is only calculated when all input values exist and the denominator is not zero. The figures are not a credit assessment.

Roles and owners

Registry data

Roles

Chief executive officer

Board

Auditor

Accountant

Source: The Brønnøysund Register Centre. We only show name and role as published by the register – never date of birth or private address.

Organisation

Structure

Organisation structure

Entity type
Main entity
Parent entity
Not stated
Number of sub-units
3

Overview

Structure map

PHARMAQ AS
  • PHARMAQ AS AVD KLØFTA

    KLØFTA · 47 employees

  • PHARMAQ AS AVD OSLO

    OSLO · 133 employees

  • PHARMAQ AS AVD OVERHALLA

    OVERHALLA · 117 employees

Registry data

Sub-units

NameOrg. no.PlaceEmployees
PHARMAQ AS AVD KLØFTAManufacture of pharmaceutical preparations925 742 228KLØFTA47
PHARMAQ AS AVD OSLOManufacture of pharmaceutical preparations990 328 560OSLO133
PHARMAQ AS AVD OVERHALLAManufacture of pharmaceutical preparations976 191 676OVERHALLA117

More about the company

This has not been registered yet. We never show made-up information.

  • Services and products

    The company has not added any services yet.

  • Public approvals

    Not in the Norwegian Building Authority's central approval register.

  • Public contracts

    No notices found in TED where the company is a supplier or contracting authority.

  • Registered changes

    We show changes from the Brønnøysund Register Centre's change log from the next registered change.

  • Documents

    Certificates of registration and other documents require a separate agreement with a document provider.

Claim the profile and add services

Transparency

Sources and data quality

  • Company information

    Brønnøysund Register Centre · Public register

    Last retrieved 21 November 2026 at 17:59

    Open official source
  • Roles

    Brønnøysund Register Centre · Public register

    Last retrieved 21 November 2026 at 17:59

    Open official source
  • Accounts and key figures

    Register of Company Accounts · Public register

    Last retrieved 21 November 2026 at 17:59

    Open official source
  • Central approval

    Norwegian Building Authority (DiBK) · No approval found

    Last retrieved 21 November 2026 at 17:59

    Open official source
  • Industry standard (SN2007)

    Statistics Norway – KLASS · Official standard

    Last retrieved 21 November 2026 at 17:59

    Open official source

Public registry data is updated periodically and cannot be changed by the company. Calculated figures are marked “Calculated by us”.

Report an error

Source

Public registry fields on this page come from the Central Coordinating Register and cannot be changed by the company. Self-reported content is marked separately.

Read about the data sources

Talk to Proffi

From company data to new customers – we show you how

Leave your contact details and an adviser will explain how segmentation, company profiles and supplier search can support your business.

Your contact details